The European Joint Doctorate (EJD) INTRICARE is set to address the urgent and unmet medical needs concerning vulnerable plaques.
The programme is funded under the Horizon 2020 Marie Skłodowska-Curie Actions (MSCA) between CARIM/MUMC+ Maastricht, the Netherlands; Universitätsklinikum Aachen, Germany; Karolinska Institutet Stockholm, Sweden; and King’s College London, UK.
INTRICARE will be guided by the academic and industrial demand for a new generation of entrepreneurial scientists, who have the skills, expertise and knowhow to accelerate the understanding of early atherosclerosis and translate this into concrete clinical interventions for prevention and therapy.
The project comprises of an international consortium involving four leading academic institutions and nine SMEs. The 15 early stage researchers (ESRs) are to engage in network-wide training events, public engagement activities and international collaboration through secondments, at industrial or academic partner institutions within the EU.
The INTRICARE ESRs will be pivotal in the identification of selective targets for vascular calcification including microcalcification, and its consequences for plaque stability, and provide subsequent strategies for prevention or amelioration of vulnerable plaque formation, both during as well as beyond the INTRICARE project.
The consortium is shaped to cover the complete spectrum of relevant expertise from chemistry, biochemistry, and vascular biology to clinical disciplines such as radiology, cardiology, nephrology, and pharmacology.
The starting dates for all ESRs are between 1 March 2017 and 1 March, 2018.